Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
Stanford University
The Netherlands Cancer Institute
Icahn School of Medicine at Mount Sinai
Brown University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rigshospitalet, Denmark
Alliance for Clinical Trials in Oncology
NYU Langone Health